2022
DOI: 10.1007/s11011-022-01084-4
|View full text |Cite
|
Sign up to set email alerts
|

The effects of polyvinyl alcohol-coated selenium nanoparticles on memory impairment in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 66 publications
0
3
0
Order By: Relevance
“…Baldinotti and others [211] reported that in a mouse model of AD induced by intracerebroventricular (ICV) infusion of STZ, intragastric pretreatment with selenium in the form of octylseleno-xylofuranoside can prevent cognitive and memory decline that may be mediated by decreased lipid peroxidation and its modulatory effects on neurotransmission, as evidenced by changes in acetylcholinesterase and monoamine oxidase. Using a similar STZ-induced AD model in rats, Hashemi-Firouzi and others also demonstrated that oral gavage of selenium nanoparticles (SeNP) or polyvinyl alcohol-coated SeNP for one month significantly enhanced hippocampal BDNF and TAC, lowered malondialdehyde and amyloid plaques, as well as markedly alleviated cognitive and memory deficits as assessed by novel object recognition and passive avoidance learning tests [212]. SeNP was also shown for its ability to enter cells via endocytosis in Aβ-treated PC12 cells to effectively inhibit ROS and inflammatory and apoptotic responses while promoting expressions of BDNF and phosphorylation of AKT and CREB [250].…”
Section: Seleniummentioning
confidence: 96%
See 1 more Smart Citation
“…Baldinotti and others [211] reported that in a mouse model of AD induced by intracerebroventricular (ICV) infusion of STZ, intragastric pretreatment with selenium in the form of octylseleno-xylofuranoside can prevent cognitive and memory decline that may be mediated by decreased lipid peroxidation and its modulatory effects on neurotransmission, as evidenced by changes in acetylcholinesterase and monoamine oxidase. Using a similar STZ-induced AD model in rats, Hashemi-Firouzi and others also demonstrated that oral gavage of selenium nanoparticles (SeNP) or polyvinyl alcohol-coated SeNP for one month significantly enhanced hippocampal BDNF and TAC, lowered malondialdehyde and amyloid plaques, as well as markedly alleviated cognitive and memory deficits as assessed by novel object recognition and passive avoidance learning tests [212]. SeNP was also shown for its ability to enter cells via endocytosis in Aβ-treated PC12 cells to effectively inhibit ROS and inflammatory and apoptotic responses while promoting expressions of BDNF and phosphorylation of AKT and CREB [250].…”
Section: Seleniummentioning
confidence: 96%
“…Lowers risk of cognitive impairment [190,191] ↓ Aβ, ↓ pTau, ↑ cognition [192][193][194][195][196][197] Se ↓ Aβ [198], associated with improved cognition [199][200][201] or cognitive dysfunction [202,203] ↓ Aβ, ↓ pTau, ↑ cognition [204][205][206][207][208][209][210][211][212][213] Fe Associated with cognitive impairment [214] or no association with AD risk [215] ↓ Cognition [216], ↓ Aβ, ↓ pTau [217] Cu Association with increased AD risk [218], ↓ cognition [219] ↓ Aβ, ↓ cognition [220][221][222],…”
Section: Mgmentioning
confidence: 99%
“…They displayed high BBB permeability and effectively decomposed the preformed Aβ fibrils into nontoxic amorphous oligomers. Other Se NPs also exhibited similar therapeutic effects, such as Se NPs coated with Tet‐1 peptide and stabilized by the epigallocatechin‐3‐gallate (EGCG) (Tet‐1‐EGCG@Se), [ 179 ] the polyvinyl alcohol (PVA)‐coated SeNPs (PVA‐SeNPs), [ 180 ] the chitosan‐coated Se NPs (ChSeNPs), [ 181 ] the quercetin‐loaded Se NPs (P80‐Que@SeNPs), [ 182 ] and the selenium nanoparticles stabilized with chitosan (Ch‐SeNPs) (Table 1). [ 183 ] Furthermore, another Se NPs coated with dihydromyricetin (DMY) (Tg‐CS/DMY@SeNPs) (Table 1) ameliorate neuroinflammation through the gut microbiota‐NLRP3 inflammasome‐brain axis in APP/PS1 mice.…”
Section: Low‐dimensional Nanomaterials For Alzheimer's Disease Treatmentmentioning
confidence: 99%
“…The reactions in aqueous media often occur in the presence of certain emulsifiers or surfactants, which create stable colloidal systems that will finally contain the SeNPs. Examples of such stabilizing agents are quaternary ammonium compounds [72], polysaccharides, arabic gum [73], chondroitin sulfate [74], chitosan [75,76], carrageenan [77], lignosulfonate [78]; proteins/peptides, zein [79], beta-lactoglobulin [80], chymotrypsin [81], peanut meal peptides [82], tilapia peptides [83], and polyvinyl alcohol [84]. Physical methods of SeNPs synthesis mainly involve the exposure of selenium precursors to different radiation sources.…”
Section: Introductionmentioning
confidence: 99%